Collegeville, PA, United States of America

Kathryn J Hofman

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kathryn J Hofman. Retrieved from https://idiyas.com/inventor/kathryn-j-hofman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kathryn J Hofman: Innovator in Vaccine Development

Introduction

Kathryn J Hofman is a prominent inventor based in Collegeville, PA (US). She has made significant contributions to the field of vaccine development, particularly in relation to human papillomavirus (HPV). Her work has implications for public health and disease prevention.

Latest Patents

Kathryn holds a patent for the "Recombinant human papillomavirus type 18 vaccine." This invention is directed to vaccines for human papillomavirus type 18 and its derivatives. Her innovative approach aims to enhance the effectiveness of HPV vaccines, contributing to the fight against this virus.

Career Highlights

Kathryn is associated with Merck & Company, Inc., a leading global healthcare company. Her role at Merck has allowed her to collaborate with other experts in the field and contribute to groundbreaking research in vaccine technology.

Collaborations

Throughout her career, Kathryn has worked alongside notable colleagues such as Joseph G Joyce and Hugh A George. These collaborations have fostered an environment of innovation and have led to advancements in vaccine research.

Conclusion

Kathryn J Hofman's contributions to vaccine development, particularly her work on the HPV vaccine, highlight her role as a key innovator in the field. Her dedication to improving public health through scientific research is commendable and impactful.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…